Displaying items by tag: department of medicine

The COVID-19 pandemic has impacted many aspects of normal life, but infectious diseases experts explain ways to enjoy the semester while minimizing health risks.
New recommendations for treatment and prevention of HIV infection in adults will help guide physicians and patients in HIV therapies and treatment regimens.
Benjamin Larimer, Ph.D., has received a $1.5 million award to conduct research on a PET-based diagnostic tool that could identify patients who will respond to immunotherapy.
Integration of the telehealth platform in a multiphase optimization strategy evaluation will allow researchers to develop behavioral health approaches that are more realistic and tailored to the individual’s goals and health needs.
Project ECHO links medical professionals with an expert in a particular field in an interactive video format to boost learning and, ultimately, patient care.
Precision disease modeling involves creation of patient-specific disease models that mimic the molecular character of a condition present in a patient, enabling more precise diagnoses and treatments.
The unit is designed to provide nursing home residents with the skilled care they need while recovering from COVID-19 in a safe environment.
The UAB Nathan Shock Center received a $4.5 million grant renewal from the National Institute on Aging to further engage in cutting-edge research focused on comparative bioenergetics and aging.
A study conducted by UAB investigators has outlined that Black individuals with heart failure have a worse prognosis, even after achieving biomarker-based heart failure treatment targets.
There is a narrow window of opportunity for successfully treating major cardiovascular events, and patients risk serious consequences if they wait for symptoms to get worse before seeking medical attention.
UAB is one of just 100 sites in the nation to receive such an antimicrobial stewardship designation.
In a new trial funded through UAB’s urgent COVID-19 research program, investigators are comparing the widely available steroid methylprednisolone with dexamethasone, which lowered risk of dying by one-third in a U.K. trial this summer.
A drug that inhibits the protease plasmin is hypothesized to reduce the infectivity and virulence of the virus, as measured by reduced need for hospitalization within a week.
Drs. Vickers and Pisu will use a $3 million, five-year National Institute on Minority Health and Health Disparities grant to study barriers that may exist for GI cancer patients to access quality cancer surgery in Alabama and Mississippi.
Page 18 of 38